scemblix
novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
suprane innöndunargufa, gegndreyptur stabbi
baxter medical ab* - desfluranum inn - innöndunargufa, gegndreyptur stabbi
pregabalin medical valley hart hylki 25 mg
medical valley invest ab - pregabalinum inn - hart hylki - 25 mg
pregabalin medical valley hart hylki 75 mg
medical valley invest ab - pregabalinum inn - hart hylki - 75 mg
pregabalin medical valley hart hylki 150 mg
medical valley invest ab - pregabalinum inn - hart hylki - 150 mg
alizin vet. stungulyf, lausn 30 mg/ml
virbac s.a.* - aglepristonum inn - stungulyf, lausn - 30 mg/ml
amoxibactin vet tafla 250 mg
le vet beheer b.v. - amoxicillinum tríhýdrat - tafla - 250 mg
amoxibactin vet tafla 50 mg
le vet beheer b.v. - amoxicillinum tríhýdrat - tafla - 50 mg
drontaste (drontaltrio vet) tafla 150/144/50 mg
vetoquinol s.a. - febantelum inn; pyrantelum embónat; praziquantelum inn - tafla - 150/144/50 mg
ketabel vet. stungulyf, lausn 100 mg/ml
bela-pharma gmbh & co kg - ketaminum hýdróklóríð - stungulyf, lausn - 100 mg/ml